CEO, Peter Olofsson-Sahl presented Inicure at the #BiotechHanse event as innovative Swedish Life Science innovation for Sweden-Germany collaboration and partnership opportunities
Biotech Hanse Stockholm September – 2025
AMR Conference Basel – 2026
Inicure particppated in the AMR conference i Basel meeting research collaborators, service providers and potential future commercial partners
INCATE – Network and Support
Inicure has been awarded support from the INCATE network (Incubator for Antibacterial Therapies in Europe). Access to advice and
Seal of Excellence – EIC – Transition proposal iCURE
The EIC-Transition proposal — iCURE “Novel small molecule FPR1 agonists for treating antibiotic-resistant and chronic bacterial infections” coordinated